Physiotherapist James Benson talks about why the UK Stroke Forum Conference is such an important event for physiotherapists.
Last week, our lecturers attended two training days at our head office, at Stroke Association House, London. These form part of a schedule of activity designed to ensure they have the skills, and support needed to succeed in becoming the next generation of research leaders.
Stenting of the carotid arteries (running up the sides of the neck) is a common surgical procedure to reduce the risk of stroke. Stenting involves inserting a metal mesh into the artery to help widen it and improve blood flow.
Our policy positions set out in detail where we stand on big issues that affect stroke survivors and the wider world of stroke.
Following a stroke, many treatments are recommended by health professionals, such as medications to prevent another stroke or physiotherapy to help limb weakness. Stroke survivors often have other chronic illnesses and report finding it difficult to follow treatments recommended by their doctors, nurses and therapists.
Intracerebral haemorrhage (ICH) is a type of stroke, which is caused by bleeding in the brain, ultimately leading to brain damage, disability and often death. We currently know very little about the biological changes that occur in the brain after intracerebral haemorrhage.
Our annual Keynote Lecture showcases some of the latest advancements being made in stroke research.
This year’s Keynote Lecture was delivered by Professor Dame Nancy Rothwell, President and Vice-Chancellor of The University of Manchester. Professor Rothwell is one of the UK’s leading neuroscientists whose research focuses on inflammation in brain disease, especially stroke.
In partnership with Alzheimer's Society and the British Heart Foundation, we are delighted to announce our funding of three new awards in vascular dementia research. This constitutes a combined investment of £2.2 million into a key area of unmet need.
A collaboration of experts in stroke and vascular dementia has worked with people affected by both diseases to create a program of work that answers fundamental questions: who will develop memory and thinking problems after stroke, why does this happen, how can we treat it?
This research programme could substantially increase our understanding of how SVD develops, leading to new ways to investigate SVD and test drugs which may help treat it.